Why entrepreneurs don’t sell to listed companies anymore
The JSE of today reminds me of a hotel under lockdown rules. The infrastructure is there, but the utilisation is low and very few people are making new bookings. The long-standing guests are getting tired of empty swimming pools and boring games nights and are checking out in search of greener pastures. New listings on the JSE are becoming more …
View Post
Digging through the JSE dustbin
They say one man’s trash is another man’s treasure. It applies in the markets too. Successful investing is about buying the right shares at the right price. End of story. It doesn’t help to overpay for even the best companies in the world. The markets exist because opinions differ on whether companies are trash or treasure. Often, it’s just a …
View Post
Digging through the JSE dustbin
They say one man’s trash is another man’s treasure. It applies in the markets too. Successful investing is about buying the right shares at the right price. End of story. It doesn’t help to overpay for even the best companies in the world. The markets exist because opinions differ on whether companies are trash or treasure. Often, it’s just a …
View Post
Rolling the dice on Descendis Health
The company is actually called Ascendis Health, but one look at a share price chart and you’ll understand why I laughed when an ex-banking colleague called it Descendis Health in a chat we had a few weeks ago. With a nod to his genius, I’ve borrowed the name. If there was ever a poster child for a high-risk acquisitive strategy …
View Post
Rolling the dice on Descendis Health
The company is actually called Ascendis Health, but one look at a share price chart and you’ll understand why I laughed when an ex-banking colleague called it Descendis Health in a chat we had a few weeks ago. With a nod to his genius, I’ve borrowed the name. If there was ever a poster child for a high-risk acquisitive strategy …
View Post
Rolling the dice on Descendis Health
The company is actually called Ascendis Health, but one look at a share price chart and you’ll understand why I laughed when an ex-banking colleague called it Descendis Health in a chat we had a few weeks ago. With a nod to his genius, I’ve borrowed the name. If there was ever a poster child for a high-risk acquisitive strategy …
View Post